Press Releases

News from Omega Laboratories, Inc.

Omega 12/22/2022

Omega Laboratories, Inc. Announces Launch of Urine Drugs of Abuse Testing in Ontario, Canada

Omega Laboratories is proud to announce the launch of Urine Drugs of Abuse testing services in its state-of-the-art laboratory in Ontario, Canada.


Omega 10/04/2022

Omega Laboratories Acquires Acumium to form Omega Technology Solutions

Omega Laboratories ("Omega"), a leading provider of laboratory testing solutions, announced the acquisition of Acumium, a leading technology and software development firm. This partnership further enhances Omega's ability to provide the highest level of risk mitigation while also providing more timely results for faster clinical, court and employment decisions.


Omega 5/15/2018

Omega Laboratories Announces Groundbreaking 17-panel Hair Drug Test to Help Organizations Tackle Drug Epidemic

Omega Laboratories is proud to introduce the Omega Hair 17-panel drug test, the most comprehensive hair test ever offered. This new offering tests for 45 different substances, helping safety-sensitive employers to proactively address the growing epidemic of hard drug use around the globe.


Omega 4/27/2018

Omega Laboratories Attends United Nations Meeting on Hair Drug Testing

Omega Laboratories is honored to have participated in a meeting organized by the Institute for Safe Traffic Technologies and the Brazilian mission hosted at the United Nations in New York to discuss the rapidly growing success of hair drug testing in Brazil.


Omega 8/04/2014

Omega Laboratories Quadruples Hair Drug Testing Capabilities

Omega Laboratories, Inc. unveiled their newly completed laboratory expansion today, a project undertaken in response to the increasing global demand for testing drugs of abuse in hair. With an investment of 5 million USD, Omega's US-based headquarters now consists of over 44,000 square feet which quadruples Omega's daily testing capacity.


Omega 7/23/2013

Omega Laboratories Presents Data on Hair Specimens for Federal Workplace Drug Testing Program

Omega Laboratories, Inc. is pleased to announce that it is assisting the Drug Testing Advisory Board (DTAB) with the evaluation of hair specimens for use in the Federal Workplace Drug Testing Program. Recent concerns and data have emerged which challenge the effectiveness of traditional urine-based testing. As a result, the DTAB assembled authorities from across the drugs of abuse testing industry, including Omega's Laboratory Director Dr. David Engelhart, at its July meeting in order to thoroughly explore the testing of hair specimens as a valuable and long-needed addition to the Federal Workplace Drug Testing Program.


Omega 12/11/2012

Omega Laboratories Receives FDA 510(k) Clearance for Marijuana Metabolite (THCA) Drugs of Abuse Test Utilizing Hair and Publishes Lowest Limit of Detection

Omega has received 510(k) clearance from the Food and Drug Administration (FDA) for its Marijuana Metabolite Test, which detects the use of marijuana through human hair analysis. The Omega 510(k) submissions were evaluated by the FDA at a much more stringent level than those submissions cleared over a decade ago.


Omega 6/13/2012

Omega Laboratories Applauds the Adoption of Enzyme Immunoassay (EIA) by Major Hair Testing Laboratories

Omega Laboratories, Inc. recognizes and applauds yesterday's announcement that the remaining laboratory of those accredited by the College of American Pathologists (CAP) for forensic hair drug testing has decided to utilize Enzyme Immunoassay technology. This announcement comes after a decade of disagreement and confusion regarding differing methodologies and proprietary techniques. This change could signal that the hair testing industry has finally come to a consensus on the superiority of Enzyme Immunoassay technology as a screening method for drugs of abuse.


Omega 12/20/2011

Omega Laboratories Becomes the First Laboratory to Receive 510(k) Clearance for Oxycodone and Hydrocodone Drugs of Abuse Test for Hair

Omega Laboratories, Inc. announced that it has become the first and only laboratory to receive 510(k) clearance from the Food and Drug Administration (FDA) for its Extended Opiates Test that detects the use of Oxycodone and Hydrocodone through human hair analysis. The clearance also included the test for Codeine, Morphine and Heroin.


Omega 9/20/2011

Gordon Trucking Implements Hair Testing With Goal of Reducing New Driver Accidents

Gordon Trucking, one of the nation’s most reliable truckload carriers, has begun drug screening all applicants via hair samples with the goal of reducing new driver accidents within the first crucial months of employment. Gordon joins a growing list of carriers that perform hair testing under company authority to supplement the minimum DOT mandated urine testing requirements.


Omega 4/26/2011

C.R. England Improves Safety With Innovative Approach to Applicant Screening

C.R. England, a Salt Lake City-based global transportation provider, and Omega Laboratories, Inc. a state-of-the art drug testing facility, have announced an innovative drug screening partnership that will test the hair samples of driver applicants. This program will enhance England's preemployment drug screening process with the end result of putting safer drivers on the road.


Omega 9/21/2010

Omega Laboratories Awarded CAP Accreditation for Drug Testing of Hair

Omega Laboratories, Inc. today announced that it has received accreditation for forensic drug testing of hair from the Commission on Laboratory Accreditation of the College of American Pathologists (CAP).


Omega 11/10/2009

Omega Laboratories Awarded ISO / IEC 17025 Accreditation

Omega Laboratories, Inc. today announced that it received ISO/IEC 17025 accreditation for its analysis of drugs and drug metabolites in hair.